These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30196254)

  • 1. Recurrent giant cell tumour of the maxillary sinus and pterygoid process treated with denosumab.
    Rosa D; Dias RB; Salvador JC; Borges A
    BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30196254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
    Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
    Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
    Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
    World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Denosumab in joint preservation for patients with giant cell tumour of bone.
    Perrin DL; Visgauss JD; Wilson DA; Griffin AM; Abdul Razak AR; Ferguson PC; Wunder JS
    Bone Joint J; 2021 Jan; 103-B(1):184-191. PubMed ID: 33380180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone.
    Rutkowski P; Ferrari S; Grimer RJ; Stalley PD; Dijkstra SP; Pienkowski A; Vaz G; Wunder JS; Seeger LL; Feng A; Roberts ZJ; Bach BA
    Ann Surg Oncol; 2015 Sep; 22(9):2860-8. PubMed ID: 26033180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
    Zhang RZ; Ma TX; Qi DW; Zhao M; Hu T; Zhang GC
    Orthop Surg; 2019 Dec; 11(6):1101-1108. PubMed ID: 31762217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How safe and effective is denosumab for bone giant cell tumour?
    Errani C; Tsukamoto S; Mavrogenis AF
    Int Orthop; 2017 Nov; 41(11):2397-2400. PubMed ID: 28646421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASO Author Reflections: Preoperative Denosumab May Increase the Risk of Local Recurrence of Giant Cell Tumor of Bone after Curettage Surgery.
    Asano N; Horiuchi K
    Ann Surg Oncol; 2022 Jun; 29(6):4001. PubMed ID: 35169975
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].
    Gong LH; Liu WF; Ding Y; Zhang W; Yang YK; Yu F; Wong GQ; Huang XY; Niu XH
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):449-454. PubMed ID: 29886590
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to Denosumab in 2 Children With Recurrent Giant Cell Tumor of the Bone With Pulmonary Metastasis.
    Reddy K; Ramirez L; Kukreja K; Venkatramani R
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e215-e218. PubMed ID: 31714440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report.
    Park MJ; Ganjoo KN; Ladd AL
    J Hand Surg Am; 2015 Aug; 40(8):1620-4. PubMed ID: 25935517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denosumab salvage therapy in an 11-year-old boy with locally recurrent unresectable giant cell tumor of the lumbar spine after surgery.
    Luo Y; Xiu P; Chen H; Zeng J; Song Y; Li T
    Neurochirurgie; 2023 May; 69(3):101427. PubMed ID: 36828057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent giant cell tumour of the thoracic spine managed by total en bloc spondylectomy and denosumab therapy: a case report.
    Duan PG; Sheng YH; Deng CH; Tang BY; Yao HQ
    BMC Musculoskelet Disord; 2020 Feb; 21(1):105. PubMed ID: 32061254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Denosumab does not decrease the risk of lung metastases from bone giant cell tumour.
    Tsukamoto S; Mavrogenis AF; Leone G; Righi A; Akahane M; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM; Errani C
    Int Orthop; 2019 Feb; 43(2):483-489. PubMed ID: 30099641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
    Chawla S; Blay JY; Rutkowski P; Le Cesne A; Reichardt P; Gelderblom H; Grimer RJ; Choy E; Skubitz K; Seeger L; Schuetze SM; Henshaw R; Dai T; Jandial D; Palmerini E
    Lancet Oncol; 2019 Dec; 20(12):1719-1729. PubMed ID: 31704134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Giant cell tumour of bone in the rib cage treated with denosumab. A case report].
    Serret Miralles P; Orellana Fernández R; Parra Parente T; García-Chamón Brígido RB; Carrera Salas R
    Rev Esp Patol; 2023; 56(2):119-123. PubMed ID: 37061238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant Transformation of a Giant Cell Tumor of Bone Treated with Denosumab: A Case Report.
    Park A; Cipriano CA; Hill K; Kyriakos M; McDonald DJ
    JBJS Case Connect; 2016; 6(3):e78. PubMed ID: 29252655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review.
    Tsukamoto S; Tanaka Y; Mavrogenis AF; Kido A; Kawaguchi M; Errani C
    Clin Orthop Relat Res; 2020 May; 478(5):1076-1085. PubMed ID: 31794487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Giant cell tumour of bone in the denosumab era.
    van der Heijden L; Dijkstra PDS; Blay JY; Gelderblom H
    Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.